Mortality due to IPF and mesothelioma in Europe – A link with historic asbestos use?

Christopher Barber (Sheffield, United Kingdom), Christopher Barber, Ruth Wiggans, David Fishwick

Source: International Congress 2016 – Population-based insights into occupational and environmental lung disease
Session: Population-based insights into occupational and environmental lung disease
Session type: Oral Presentation
Number: 457
Disease area: Interstitial lung diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Christopher Barber (Sheffield, United Kingdom), Christopher Barber, Ruth Wiggans, David Fishwick. Mortality due to IPF and mesothelioma in Europe – A link with historic asbestos use?. Eur Respir J 2016; 48: Suppl. 60, 457

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: Idiopathic Pulmonary Fibrosis, asbestosis and mesothelioma, trends for England and Wales: is asbestos exposure associated with IPF?
Source: International Congress 2014 – Occupational, indoor and outdoor environments and COPD
Year: 2014


Distribution of pleural plaques and pulmonary fibrosis due to asbestos exposure: Radiological patterns in asbestos-related disorders (ARDs)
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015


Incidence and prevalence of IPF in an insurance claims database: Assessing accuracy using medical records
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014


Risk factors for idiopathic pulmonary fibrosis in Southern Europe: A case-control study
Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis
Year: 2013

Prevalence and incidence of interstitial lung diseases (ILDs) in a French multi-ethnic county
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013

Inspiration plus: baseline characteristics of the canadian registry for IPF patients on pirfenidone
Source: International Congress 2016 – Orphan diseases II
Year: 2016

The epidemiologic features and the patterns of medical resource use in idiopathic pulmonary fibrosis (IPF) in Korea
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


Prevalence of occupational and environmental exposures in Australian patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – Occupational asthma, abestosis and silicosis
Year: 2014

Incidence of idiopathic pulmonary fibrosis in Italy. Analysis of hospital admission and mortality databases of a large Italian region
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

Establishment of the consecutive registration system for pulmonary alveolar proteinosis in Japan: Updated incidence, prevalence and surveillance for intractable cases
Source: International Congress 2016 – Orphan diseases I
Year: 2016

Types of interstitial lung diseases and comparison on survival of idiopathic and secondary types in a tertiary care setting of Sri Lanka
Source: International Congress 2014 – ILDs 6
Year: 2014

Lung function of idiopathic pulmonary fibrosis: Russian IPF registry (Moscow region)
Source: International Congress 2019 – Respiratory function assessment in disease
Year: 2019


Disease progression in early idiopathic pulmonary fibrosis: Insights from the Australian IPF registry
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016


Quality of life of patients with idiopathic pulmonary fibrosis (IPF) - What can the Australian IPF registry tell us?
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015



Idiopathic pulmonary fibrosis mortality in the United States: is there any evidence of occupational risk?
Source: Eur Respir J 2005; 26: Suppl. 49, 702s
Year: 2005

Idiopathic pulmonary fibrosis: asbestos exposure, smoking and lung cancer risk
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009


Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada
Source: Eur Respir J 2016; 48: 187-195
Year: 2016



Health-related quality of life in idiopathic pulmonary fibrosis (IPF): First results based on the European IPF registry
Source: International Congress 2014 – ILDs 1
Year: 2014

Rare pneumoconioses
Source: Annual Congress 2005 - Update on orphan lung diseases
Year: 2005

Rare interstitial lung diseases of environmental origin
Source: Eur Respir Mon 2011; 54: 301-316
Year: 2011